Procedural and Clinical Outcomes in Transcatheter Aortic Valve Replacement for Bicuspid Versus Tricuspid Aortic Valve Stenosis. En savoir plus sur Procedural and Clinical Outcomes in Transcatheter Aortic Valve Replacement for Bicuspid Versus Tricuspid Aortic Valve Stenosis.
Long-term serial non-invasive multislice computed tomography angiography with functional evaluation after coronary implantation of a bioresorbable everolimus-eluting scaffold: the ABSORB cohort B MSCT substudy. En savoir plus sur Long-term serial non-invasive multislice computed tomography angiography with functional evaluation after coronary implantation of a bioresorbable everolimus-eluting scaffold: the ABSORB cohort B MSCT substudy.
Does geographical variability influence 5-year MACCE rates in the multicenter SYNTAX revascularization trial? En savoir plus sur Does geographical variability influence 5-year MACCE rates in the multicenter SYNTAX revascularization trial?
Efficacy and Safety of the Absorb Everolimus-Eluting Bioresorbable Scaffold for Treatment of Patients With Diabetes Mellitus: Results of the Absorb Diabetic Substudy. En savoir plus sur Efficacy and Safety of the Absorb Everolimus-Eluting Bioresorbable Scaffold for Treatment of Patients With Diabetes Mellitus: Results of the Absorb Diabetic Substudy.
Randomised comparison of a bioresorbable everolimus-eluting scaffold with a metallic everolimus-eluting stent for ischaemic heart disease caused by de novo native coronary artery lesions: the 2-year clinical outcomes of the ABSORB II trial. En savoir plus sur Randomised comparison of a bioresorbable everolimus-eluting scaffold with a metallic everolimus-eluting stent for ischaemic heart disease caused by de novo native coronary artery lesions: the 2-year clinical outcomes of the ABSORB II trial.
Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial. En savoir plus sur Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial.
TCT-29 Performance and healing patterns after implantation of a novel sirolimus eluting bioresorbable scaffold. Six-month follow-up by optical coherence tomography in the FANTOM II study. En savoir plus sur TCT-29 Performance and healing patterns after implantation of a novel sirolimus eluting bioresorbable scaffold. Six-month follow-up by optical coherence tomography in the FANTOM II study.
TCT-742 Transcatheter aortic valve implantation in patients aged ≤75 years versus >75 years: a matched comparison. En savoir plus sur TCT-742 Transcatheter aortic valve implantation in patients aged ≤75 years versus >75 years: a matched comparison.
TCT-234 Rotablation in centres with a default radial approach for angioplasty - does a burr necessitate femoral access? En savoir plus sur TCT-234 Rotablation in centres with a default radial approach for angioplasty - does a burr necessitate femoral access?
Comparative assessment of "plaque/media" change on three modalities of IVUS immediately after implantation of either everolimus-eluting bioresorbable vascular scaffold or everolimus-eluting metallic stent in Absorb II study. En savoir plus sur Comparative assessment of "plaque/media" change on three modalities of IVUS immediately after implantation of either everolimus-eluting bioresorbable vascular scaffold or everolimus-eluting metallic stent in Absorb II study.